Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases

NCT05794971 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Liver Metastases
Regorafenib

Interventions

DRUG: Regorafenib and DIBIRI
DRUG: Regorafenib

Sponsor

Sun Yat-sen University